Shares of Castle Biosciences fell 6.91% to $60.45 at 12:30 EST on Tuesday, after four consecutive sessions in a row of losses. NASDAQ Composite is dropping 1.09% to $13,762.59, following last session’s downward trend, This seems, up until now, an all-around rough trend exchanging session today.
Castle Biosciences’s last close was $64.94, 78.15% below its 52-week high of $107.69.
The company’s growth estimates for the current quarter and the next is a negative 900% and a negative 150%, respectively.
Castle Biosciences’s Revenue
Year-on-year quarterly revenue growth declined by 1.9%, now sitting on 62.65M for the twelve trailing months.
Castle Biosciences’s Stock Yearly Top and Bottom Value
Castle Biosciences’s stock is valued at $60.45 at 12:30 EST, way under its 52-week high of $107.69 and way above its 52-week low of $26.13.
Castle Biosciences’s Moving Average
Castle Biosciences’s value is way under its 50-day moving average of $71.54 and below its 200-day moving average of $63.56.
More news about Castle Biosciences.